Kenya Rx pharma market to grow 11.8% a year
Kenya’s prescription pharmaceuticals market was worth $423.2 million last year, and is set to increase at a compound annual growth rate (CAGR) of 11.8% to 2019, say new forecasts.
The market is heavily dependent on the private clientele, and affordability remains a primary restraint, together with low reimbursement rates, says the research, from Frost & Sullivan.
Increasingly, urban consumers constitute Kenya’s primary.... Read more »
Posted on : Thursday , 9th October 2014



















